Model for monitoring Alzheimer's disease cell cycl-G2 / M period and construction method and application thereof

CN119534849APending Publication Date: 2025-02-28ZHENJIANG NO 4 PEOPLES HOSPITAL +2
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410452106.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-04-16
Publication Date
2025-02-28

AI Technical Summary

Technical Problem

The prior art is difficult to effectively monitor and regulate G2/M phase block of neuronal cell cycle in Alzheimer's disease, making the treatment difficult to work.

Method used

APP/PS1 dual transgenic mice were hybridized with Fucci-Green (G2/M phase) reporter mice through gene recombination technology, and a G2/M phase-Fucci-Green reporter mouse model was constructed in the Alzheimer's disease cell cycle, and the number of cells in the G2/M phase was detected by immunofluorescence technology.

Benefits of technology

It has achieved efficient monitoring of the number of cells in the G2/M phase of the cell cycle of Alzheimer's disease, provided an important tool for screening therapeutic drugs and studying disease mechanisms, and is of good practicality.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 00000000_0000_ABST
    Figure 00000000_0000_ABST
Patent Text Reader

Abstract

The invention provides a model for monitoring Alzheimer's disease cell cycl-G2 / M period as well as a construction method and application thereof, and belongs to the technical field of biology. According to the invention, an APP / PS1 double transgenic mouse and a Fucci-Green (G2 / M stage) reporter gene mouse are hybridized through a gene recombination technology to obtain an Alzheimer's disease cell cycle G2 / M stage-Fucci-Green reporter gene mouse APP / PS1:: mAG-hGem( 1 / 110), namely a model mouse for monitoring the Alzheimer's disease cell cycle G2 / M stage; the model mouse for monitoring the cell cycle of the Alzheimer's disease can be used for screening Alzheimer's disease treatment drugs, has important significance on mechanism research of the Alzheimer's disease and targeted drug development, and has good practicability.
Need to check novelty before this filing date? Find Prior Art